225 related articles for article (PubMed ID: 2528051)
1. Mortality and morbidity in transsexual patients with cross-gender hormone treatment.
Asscheman H; Gooren LJ; Eklund PL
Metabolism; 1989 Sep; 38(9):869-73. PubMed ID: 2528051
[TBL] [Abstract][Full Text] [Related]
2. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones.
Asscheman H; Giltay EJ; Megens JA; de Ronde WP; van Trotsenburg MA; Gooren LJ
Eur J Endocrinol; 2011 Apr; 164(4):635-42. PubMed ID: 21266549
[TBL] [Abstract][Full Text] [Related]
3. Mortality and morbidity in transsexual subjects treated with cross-sex hormones.
van Kesteren PJ; Asscheman H; Megens JA; Gooren LJ
Clin Endocrinol (Oxf); 1997 Sep; 47(3):337-42. PubMed ID: 9373456
[TBL] [Abstract][Full Text] [Related]
4. [Morbidity in transsexual patients with cross-gender hormone self-treatment].
Becerra Fernández A; de Luis Román DA; Piédrola Maroto G
Med Clin (Barc); 1999 Oct; 113(13):484-7. PubMed ID: 10604171
[TBL] [Abstract][Full Text] [Related]
5. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people.
Toorians AW; Thomassen MC; Zweegman S; Magdeleyns EJ; Tans G; Gooren LJ; Rosing J
J Clin Endocrinol Metab; 2003 Dec; 88(12):5723-9. PubMed ID: 14671159
[TBL] [Abstract][Full Text] [Related]
6. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence.
Wierckx K; Van Caenegem E; Schreiner T; Haraldsen I; Fisher AD; Toye K; Kaufman JM; T'Sjoen G
J Sex Med; 2014 Aug; 11(8):1999-2011. PubMed ID: 24828032
[TBL] [Abstract][Full Text] [Related]
7. Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review.
Mancini I; Rotilio A; Coati I; Seracchioli R; Martelli V; Meriggiola MC
Gynecol Endocrinol; 2018 Jun; 34(6):456-459. PubMed ID: 29105524
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience.
Gooren LJ; Giltay EJ; Bunck MC
J Clin Endocrinol Metab; 2008 Jan; 93(1):19-25. PubMed ID: 17986639
[TBL] [Abstract][Full Text] [Related]
9. Conjectures concerning cross-sex hormone treatment of aging transsexual persons.
Gooren L; Lips P
J Sex Med; 2014 Aug; 11(8):2012-9. PubMed ID: 24775178
[TBL] [Abstract][Full Text] [Related]
10. Cross-sex hormone administration changes pain in transsexual women and men.
Aloisi AM; Bachiocco V; Costantino A; Stefani R; Ceccarelli I; Bertaccini A; Meriggiola MC
Pain; 2007 Nov; 132 Suppl 1():S60-S67. PubMed ID: 17379410
[TBL] [Abstract][Full Text] [Related]
11. Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects.
Moore E; Wisniewski A; Dobs A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3467-73. PubMed ID: 12915619
[TBL] [Abstract][Full Text] [Related]
12. Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals.
Zubiaurre-Elorza L; Junque C; Gómez-Gil E; Guillamon A
J Sex Med; 2014 May; 11(5):1248-61. PubMed ID: 24617977
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of cross-sex hormone treatment in transsexual persons.
Wierckx K; Mueller S; Weyers S; Van Caenegem E; Roef G; Heylens G; T'Sjoen G
J Sex Med; 2012 Oct; 9(10):2641-51. PubMed ID: 22906135
[TBL] [Abstract][Full Text] [Related]
14. Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals.
Elbers JM; Asscheman H; Seidell JC; Frölich M; Meinders AE; Gooren LJ
J Clin Endocrinol Metab; 1997 Oct; 82(10):3267-70. PubMed ID: 9329351
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer development in transsexual subjects receiving cross-sex hormone treatment.
Gooren LJ; van Trotsenburg MA; Giltay EJ; van Diest PJ
J Sex Med; 2013 Dec; 10(12):3129-34. PubMed ID: 24010586
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual.
Bergoglio MT; Gómez-Balaguer M; Almonacid Folch E; Hurtado Murillo F; Hernández-Mijares A
Endocrinol Nutr; 2013 May; 60(5):264-7. PubMed ID: 23022362
[TBL] [Abstract][Full Text] [Related]
17. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.
Slabbekoorn D; van Goozen SH; Megens J; Gooren LJ; Cohen-Kettenis PT
Psychoneuroendocrinology; 1999 May; 24(4):423-47. PubMed ID: 10341369
[TBL] [Abstract][Full Text] [Related]
18. Hormone treatment of the adult transsexual patient.
Gooren L
Horm Res; 2005; 64 Suppl 2():31-6. PubMed ID: 16286768
[TBL] [Abstract][Full Text] [Related]
19. People with gender dysphoria who self-prescribe cross-sex hormones: prevalence, sources, and side effects knowledge.
Mepham N; Bouman WP; Arcelus J; Hayter M; Wylie KR
J Sex Med; 2014 Dec; 11(12):2995-3001. PubMed ID: 25213018
[TBL] [Abstract][Full Text] [Related]
20. Profound Changes in Sex Hormone Levels during Cross-Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity.
Wultsch A; Kaufmann U; Ott J; Stojakovic T; Scharnagl H; Stangl H; Strobl WM
J Sex Med; 2015 Jun; 12(6):1436-9. PubMed ID: 25854918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
